 | • レポートコード：QY2108PAL8882 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるメベンダゾールの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、メベンダゾールの種類別市場規模（錠剤、経口懸濁液）、用途別市場規模（2歳以下、2歳以上）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のメベンダゾール市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるメベンダゾールの種類別市場規模（2016年-2027年）：錠剤、経口懸濁液 ・世界におけるメベンダゾールの用途別市場規模（2016年-2027年）：2歳以下、2歳以上 ・メベンダゾールの中国市場分析 - メベンダゾールの中国市場規模（2016年-2027年） - 中国におけるメベンダゾールの主要プレイヤー別市場シェア - 中国におけるメベンダゾールの種類別市場規模：錠剤、経口懸濁液 - 中国におけるメベンダゾールの用途別市場規模：2歳以下、2歳以上 ・メベンダゾールの北米市場（2016年-2027年） ・メベンダゾールのヨーロッパ市場（2016年-2027年） ・メベンダゾールのアジア太平洋市場（2016年-2027年） ・メベンダゾールの中南米市場（2016年-2027年） ・メベンダゾールの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Johnson & Johnson、Amneal Pharmaceuticals、Cadila Pharmaceuticals、Eipico、Esteve Pharmaceuticals、Tenry ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
Market Analysis and Insights: Global and China Mebendazole Market
This report focuses on global and China Mebendazole market.
In 2020, the global Mebendazole market size was US$ 111.3 million and it is expected to reach US$ 163 million by the end of 2027, with a CAGR of 5.6% during 2021-2027. In China the Mebendazole market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Mebendazole Scope and Market Size
Mebendazole market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Mebendazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Mebendazole market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Tablet
Oral Suspension
Segment by Application
Below 2 Years Old
Above 2 Years Old
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
1 Study Coverage
1.1 Mebendazole Product Introduction
1.2 Market by Type
1.2.1 Global Mebendazole Market Size Growth Rate by Type
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Market by Application
1.3.1 Global Mebendazole Market Size Growth Rate by Application
1.3.2 Below 2 Years Old
1.3.3 Above 2 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mebendazole Market Size, Estimates and Forecasts
2.1.1 Global Mebendazole Revenue 2016-2027
2.1.2 Global Mebendazole Sales 2016-2027
2.2 Global Mebendazole, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Mebendazole Historical Market Size by Region (2016-2021)
2.3.1 Global Mebendazole Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Mebendazole Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Mebendazole Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Mebendazole Sales Forecast by Region (2022-2027)
2.4.2 Global Mebendazole Revenue Forecast by Region (2022-2027)
3 Global Mebendazole Competitor Landscape by Players
3.1 Global Top Mebendazole Manufacturers by Sales
3.1.1 Global Mebendazole Sales by Manufacturer (2016-2021)
3.1.2 Global Mebendazole Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Mebendazole Manufacturers by Revenue
3.2.1 Key Mebendazole Manufacturers Covered: Ranking by Revenue
3.2.2 Global Mebendazole Revenue by Manufacturers (2016-2021)
3.2.3 Global Mebendazole Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Mebendazole Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Mebendazole Revenue in 2020
3.2.6 Global Mebendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Mebendazole Price by Manufacturers
3.4 Global Mebendazole Manufacturing Base Distribution, Product Types
3.4.1 Mebendazole Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mebendazole Product Type
3.4.3 Date of International Manufacturers Enter into Mebendazole Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Mebendazole Market Size by Type (2016-2021)
4.1.1 Global Mebendazole Sales by Type (2016-2021)
4.1.2 Global Mebendazole Revenue by Type (2016-2021)
4.1.3 Mebendazole Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Mebendazole Market Size Forecast by Type (2022-2027)
4.2.1 Global Mebendazole Sales Forecast by Type (2022-2027)
4.2.2 Global Mebendazole Revenue Forecast by Type (2022-2027)
4.2.3 Mebendazole Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Mebendazole Market Size by Application (2016-2021)
5.1.1 Global Mebendazole Sales by Application (2016-2021)
5.1.2 Global Mebendazole Revenue by Application (2016-2021)
5.1.3 Mebendazole Price by Application (2016-2021)
5.2 Mebendazole Market Size Forecast by Application (2022-2027)
5.2.1 Global Mebendazole Sales Forecast by Application (2022-2027)
5.2.2 Global Mebendazole Revenue Forecast by Application (2022-2027)
5.2.3 Global Mebendazole Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Mebendazole Market Size YoY Growth 2016-2027
6.1.1 China Mebendazole Sales YoY Growth 2016-2027
6.1.2 China Mebendazole Revenue YoY Growth 2016-2027
6.1.3 China Mebendazole Market Share in Global Market 2016-2027
6.2 China Mebendazole Market Size by Players (International and Local Players)
6.2.1 China Top Mebendazole Players by Sales (2016-2021)
6.2.2 China Top Mebendazole Players by Revenue (2016-2021)
6.3 China Mebendazole Historic Market Review by Type (2016-2021)
6.3.1 China Mebendazole Sales Market Share by Type (2016-2021)
6.3.2 China Mebendazole Revenue Market Share by Type (2016-2021)
6.3.3 China Mebendazole Price by Type (2016-2021)
6.4 China Mebendazole Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Mebendazole Sales Forecast by Type (2022-2027)
6.4.2 China Mebendazole Revenue Forecast by Type (2022-2027)
6.4.3 China Mebendazole Price Forecast by Type (2022-2027)
6.5 China Mebendazole Historic Market Review by Application (2016-2021)
6.5.1 China Mebendazole Sales Market Share by Application (2016-2021)
6.5.2 China Mebendazole Revenue Market Share by Application (2016-2021)
6.5.3 China Mebendazole Price by Application (2016-2021)
6.6 China Mebendazole Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Mebendazole Sales Forecast by Application (2022-2027)
6.6.2 China Mebendazole Revenue Forecast by Application (2022-2027)
6.6.3 China Mebendazole Price Forecast by Application (2022-2027)
7 North America
7.1 North America Mebendazole Market Size YoY Growth 2016-2027
7.2 North America Mebendazole Market Facts & Figures by Country
7.2.1 North America Mebendazole Sales by Country (2016-2021)
7.2.2 North America Mebendazole Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Mebendazole Market Size YoY Growth 2016-2027
8.2 Asia Pacific Mebendazole Market Facts & Figures by Region
8.2.1 Asia Pacific Mebendazole Sales by Region (2016-2021)
8.2.2 Asia Pacific Mebendazole Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Mebendazole Market Size YoY Growth 2016-2027
9.2 Europe Mebendazole Market Facts & Figures by Country
9.2.1 Europe Mebendazole Sales by Country (2016-2021)
9.2.2 Europe Mebendazole Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Mebendazole Market Size YoY Growth 2016-2027
10.2 Latin America Mebendazole Market Facts & Figures by Country
10.2.1 Latin America Mebendazole Sales by Country (2016-2021)
10.2.2 Latin America Mebendazole Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Mebendazole Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Mebendazole Market Facts & Figures by Country
11.2.1 Middle East and Africa Mebendazole Sales by Country (2016-2021)
11.2.2 Middle East and Africa Mebendazole Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Description and Business Overview
12.1.3 Johnson & Johnson Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson & Johnson Mebendazole Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Amneal Pharmaceuticals
12.2.1 Amneal Pharmaceuticals Corporation Information
12.2.2 Amneal Pharmaceuticals Description and Business Overview
12.2.3 Amneal Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amneal Pharmaceuticals Mebendazole Products Offered
12.2.5 Amneal Pharmaceuticals Recent Development
12.3 Cadila Pharmaceuticals
12.3.1 Cadila Pharmaceuticals Corporation Information
12.3.2 Cadila Pharmaceuticals Description and Business Overview
12.3.3 Cadila Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cadila Pharmaceuticals Mebendazole Products Offered
12.3.5 Cadila Pharmaceuticals Recent Development
12.4 Eipico
12.4.1 Eipico Corporation Information
12.4.2 Eipico Description and Business Overview
12.4.3 Eipico Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eipico Mebendazole Products Offered
12.4.5 Eipico Recent Development
12.5 Esteve Pharmaceuticals
12.5.1 Esteve Pharmaceuticals Corporation Information
12.5.2 Esteve Pharmaceuticals Description and Business Overview
12.5.3 Esteve Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Esteve Pharmaceuticals Mebendazole Products Offered
12.5.5 Esteve Pharmaceuticals Recent Development
12.6 Tenry
12.6.1 Tenry Corporation Information
12.6.2 Tenry Description and Business Overview
12.6.3 Tenry Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Tenry Mebendazole Products Offered
12.6.5 Tenry Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Description and Business Overview
12.11.3 Johnson & Johnson Mebendazole Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson & Johnson Mebendazole Products Offered
12.11.5 Johnson & Johnson Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Mebendazole Industry Trends
13.2 Mebendazole Market Drivers
13.3 Mebendazole Market Challenges
13.4 Mebendazole Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mebendazole Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Mebendazole Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Oral Suspension
Table 4. Global Mebendazole Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Mebendazole Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Mebendazole Sales by Regions (2016-2021) & (K Units)
Table 7. Global Mebendazole Sales Market Share by Regions (2016-2021)
Table 8. Global Mebendazole Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Mebendazole Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Mebendazole Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Mebendazole Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Mebendazole Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Mebendazole Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Mebendazole Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Mebendazole Manufacturers by Revenue (US$ Million) in 2020
Table 16. Mebendazole Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Mebendazole Revenue Share by Manufacturers (2016-2021)
Table 18. Global Mebendazole Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Mebendazole by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mebendazole as of 2020)
Table 20. Key Manufacturers Mebendazole Price (2016-2021) (USD/Unit)
Table 21. Mebendazole Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Mebendazole Product Type
Table 23. Date of International Manufacturers Enter into Mebendazole Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Mebendazole Sales by Type (2016-2021) (K Units)
Table 26. Global Mebendazole Sales Share by Type (2016-2021)
Table 27. Global Mebendazole Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Mebendazole Revenue Share by Type (2016-2021)
Table 29. Mebendazole Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Mebendazole Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Mebendazole Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Mebendazole Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Mebendazole Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Mebendazole Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Mebendazole Sales by Application (2016-2021) (K Units)
Table 36. Global Mebendazole Sales Share by Application (2016-2021)
Table 37. Global Mebendazole Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Mebendazole Revenue Share by Application (2016-2021)
Table 39. Mebendazole Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Mebendazole Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Mebendazole Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Mebendazole Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Mebendazole Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Mebendazole Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. China Mebendazole Sales (K Units) of Key Companies (2016-2021)
Table 46. China Mebendazole Sales Share by Company (2016-2021)
Table 47. China Mebendazole Revenue (US$ Million) by Company (2016-2021)
Table 48. China Mebendazole Revenue Share by Company (2016-2021)
Table 49. China Mebendazole Sales (K Units) by Type (2016-2021)
Table 50. China Mebendazole Sales Share by Type (2016-2021)
Table 51. China Mebendazole Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Mebendazole Price (USD/Unit) by Type (2016-2021)
Table 53. China Mebendazole Sales (K Units) by Type (2022-2027)
Table 54. China Mebendazole Sales Share by Type (2022-2027)
Table 55. China Mebendazole Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Mebendazole Revenue Share by Type (2022-2027)
Table 57. China Mebendazole Price (USD/Unit) by Type (2022-2027)
Table 58. China Mebendazole Sales (K Units) by Application (2016-2021)
Table 59. China Mebendazole Sales Share by Application (2016-2021)
Table 60. China Mebendazole Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Mebendazole Price (USD/Unit) by Application (2016-2021)
Table 62. China Mebendazole Sales (K Units) by Application (2022-2027)
Table 63. China Mebendazole Sales Share by Application (2022-2027)
Table 64. China Mebendazole Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Mebendazole Revenue Share by Application (2022-2027)
Table 66. China Mebendazole Price (USD/Unit) by Application (2022-2027)
Table 67. North America Mebendazole Sales by Country (2016-2021) & (K Units)
Table 68. North America Mebendazole Sales Market Share by Country (2016-2021)
Table 69. North America Mebendazole Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Mebendazole Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Mebendazole Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Mebendazole Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Mebendazole Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Mebendazole Revenue Market Share by Region (2016-2021)
Table 75. Europe Mebendazole Sales by Country (2016-2021) & (K Units)
Table 76. Europe Mebendazole Sales Market Share by Country (2016-2021)
Table 77. Europe Mebendazole Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Mebendazole Revenue Market Share by Country (2016-2021)
Table 79. Latin America Mebendazole Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Mebendazole Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Mebendazole Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Mebendazole Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Mebendazole Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Mebendazole Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Mebendazole Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Mebendazole Revenue Market Share by Country (2016-2021)
Table 87. Johnson & Johnson Corporation Information
Table 88. Johnson & Johnson Description and Business Overview
Table 89. Johnson & Johnson Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Johnson & Johnson Mebendazole Product
Table 91. Johnson & Johnson Recent Development
Table 92. Amneal Pharmaceuticals Corporation Information
Table 93. Amneal Pharmaceuticals Description and Business Overview
Table 94. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Amneal Pharmaceuticals Product
Table 96. Amneal Pharmaceuticals Recent Development
Table 97. Cadila Pharmaceuticals Corporation Information
Table 98. Cadila Pharmaceuticals Description and Business Overview
Table 99. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Cadila Pharmaceuticals Product
Table 101. Cadila Pharmaceuticals Recent Development
Table 102. Eipico Corporation Information
Table 103. Eipico Description and Business Overview
Table 104. Eipico Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Eipico Product
Table 106. Eipico Recent Development
Table 107. Esteve Pharmaceuticals Corporation Information
Table 108. Esteve Pharmaceuticals Description and Business Overview
Table 109. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Esteve Pharmaceuticals Product
Table 111. Esteve Pharmaceuticals Recent Development
Table 112. Tenry Corporation Information
Table 113. Tenry Description and Business Overview
Table 114. Tenry Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Tenry Product
Table 116. Tenry Recent Development
Table 117. Mebendazole Market Trends
Table 118. Mebendazole Market Drivers
Table 119. Mebendazole Market Challenges
Table 120. Mebendazole Market Restraints
Table 121. Mebendazole Customers List
Table 122. Mebendazole Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Mebendazole Product Picture
Figure 2. Global Mebendazole Sales Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Oral Suspension Product Picture
Figure 5. Global Mebendazole Sales Market Share by Application in 2020 & 2027
Figure 6. Below 2 Years Old
Figure 7. Above 2 Years Old
Figure 8. Mebendazole Report Years Considered
Figure 9. Global Mebendazole Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Mebendazole Market Size 2016-2027 (US$ Million)
Figure 11. Global Mebendazole Sales 2016-2027 (K Units)
Figure 12. Global Mebendazole Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Mebendazole Sales Market Share by Region (2016-2021)
Figure 14. Global Mebendazole Sales Market Share by Region in 2020
Figure 15. Global Mebendazole Revenue Market Share by Region (2016-2021)
Figure 16. Global Mebendazole Revenue Market Share by Region in 2020
Figure 17. Global Mebendazole Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Mebendazole Revenue in 2020
Figure 19. Mebendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Mebendazole Sales Market Share by Type (2016-2021)
Figure 21. Global Mebendazole Sales Market Share by Type in 2020
Figure 22. Global Mebendazole Revenue Market Share by Type (2016-2021)
Figure 23. Global Mebendazole Revenue Market Share by Type in 2020
Figure 24. Global Mebendazole Sales Market Share by Application (2016-2021)
Figure 25. Global Mebendazole Sales Market Share by Application in 2020
Figure 26. Global Mebendazole Revenue Market Share by Application (2016-2021)
Figure 27. Global Mebendazole Revenue Market Share by Application in 2020
Figure 28. China Mebendazole Sales Growth Rate 2016-2027 (K Units)
Figure 29. China Mebendazole Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Mebendazole Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Mebendazole Players Market Share by Revenue in Mebendazole in 2020
Figure 32. China Mebendazole Revenue Share by Type (2016-2021)
Figure 33. China Mebendazole Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Mebendazole Revenue Share by Application (2016-2021)
Figure 35. China Mebendazole Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Mebendazole Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Mebendazole Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Mebendazole Sales Market Share by Country in 2020
Figure 39. North America Mebendazole Revenue Market Share by Country in 2020
Figure 40. U.S. Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 41. U.S. Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Mebendazole Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Mebendazole Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Mebendazole Sales Market Share by Country in 2020
Figure 47. Europe Mebendazole Revenue Market Share by Country in 2020
Figure 48. Germany Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Mebendazole Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Mebendazole Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Mebendazole Sales Market Share by Region in 2020
Figure 61. Asia Pacific Mebendazole Revenue Market Share by Region in 2020
Figure 62. China Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 73. Taiwan Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 81. Philippines Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 83. Vietnam Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Mebendazole Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Mebendazole Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Mebendazole Sales Market Share by Country in 2020
Figure 87. Latin America Mebendazole Revenue Market Share by Country in 2020
Figure 88. Mexico Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 89. Mexico Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 91. Brazil Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 93. Argentina Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Mebendazole Sales Growth Rate 2016-2021 (K Units)
Figure 95. Middle East and Africa Mebendazole Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Mebendazole Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Mebendazole Revenue Market Share by Country in 2020
Figure 98. Turkey Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 99. Turkey Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 101. Saudi Arabia Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Mebendazole Sales Growth Rate (2016-2021) (K Units)
Figure 103. UAE Mebendazole Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Mebendazole Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
世界のイブプロフェン懸濁液市場インサイト・予測（～2027年） Market Analysis and Insights: Global Ibuprofen Suspension Market The global Ibuprofen Suspension market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Ibuprofen Suspension Scope and Segment Ibuprofe…- 世界の自動車用アクティブサスペンション市場インサイト・予測（～2027年） Market Analysis and Insights: Global Automotive Active Suspension Market The global Automotive Active Suspension market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Automotive Active Suspension Sc…
- 世界のエアサスペンションソレノイドバルブ市場インサイト・予測（～2027年） Market Analysis and Insights: Global Air Suspension Solenoid Valve Market The global Air Suspension Solenoid Valve market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Air Suspension Solenoid Valve…
- 電子エアサスペンションシステム（EAS）の世界及び中国市場 Electronic air suspension system (EAS) is a kind of air suspension system which is controlled by an electrical system. Electronic air suspension system uses suspension dampers equipped with external inflatable air bags to control the height of the corners of the vehicle. The dampers may be either pa…
- 世界の医療用サスペンションアーム市場インサイト・予測（～2027年） Market Analysis and Insights: Global Medical Suspension Arm Market The global Medical Suspension Arm market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Medical Suspension Arm Scope and Segment Me…